224 related articles for article (PubMed ID: 34520292)
1. ATP5A1 Participates in Transcriptional and Posttranscriptional Regulation of Cancer-Associated Genes by Modulating Their Expression and Alternative Splicing Profiles in HeLa Cells.
Song Ba Y; Wang Ma F; Wei Ma Y; Chen Ba D; Deng Ba G
Technol Cancer Res Treat; 2021; 20():15330338211039126. PubMed ID: 34520292
[No Abstract] [Full Text] [Related]
2. SERBP1 affects the apoptotic level by regulating the expression and alternative splicing of cellular and metabolic process genes in HeLa cells.
Zhou J; Chen W; He Q; Chen D; Li C; Jiang C; Ding Z; Qian Q
PeerJ; 2022; 10():e14084. PubMed ID: 36213507
[TBL] [Abstract][Full Text] [Related]
3. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
4. Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells.
Ma HR; Cao L; Wang F; Cheng C; Jiang R; Zhou H; Xie Z; Wuermanbieke S; Qian Z
Oncol Rep; 2020 May; 43(5):1536-1546. PubMed ID: 32323860
[TBL] [Abstract][Full Text] [Related]
5. DDX41 regulates the expression and alternative splicing of genes involved in tumorigenesis and immune response.
Qin K; Jian D; Xue Y; Cheng Y; Zhang P; Wei Y; Zhang J; Xiong H; Zhang Y; Yuan X
Oncol Rep; 2021 Mar; 45(3):1213-1225. PubMed ID: 33650667
[TBL] [Abstract][Full Text] [Related]
6. RBM4 modulates the proliferation and expression of inflammatory factors via the alternative splicing of regulatory factors in HeLa cells.
Wang WY; Quan W; Yang F; Wei YX; Chen JJ; Yu H; Xie J; Zhang Y; Li ZF
Mol Genet Genomics; 2020 Jan; 295(1):95-106. PubMed ID: 31489484
[TBL] [Abstract][Full Text] [Related]
7. QKI-Regulated Alternative Splicing Events in Cervical Cancer: Pivotal Mechanism and Potential Therapeutic Strategy.
Luo Y; Li Y; Ge P; Zhang K; Liu H; Jiang N
DNA Cell Biol; 2021 Oct; 40(10):1261-1277. PubMed ID: 34551268
[TBL] [Abstract][Full Text] [Related]
8. Iron metabolism protein transferrin receptor 1 involves in cervical cancer progression by affecting gene expression and alternative splicing in HeLa cells.
Huang N; Wei Y; Cheng Y; Wang X; Wang Q; Chen D; Li W
Genes Genomics; 2022 Jun; 44(6):637-650. PubMed ID: 35066810
[TBL] [Abstract][Full Text] [Related]
9. ATP5A1 and ATP5B are highly expressed in glioblastoma tumor cells and endothelial cells of microvascular proliferation.
Xu G; Li JY
J Neurooncol; 2016 Feb; 126(3):405-13. PubMed ID: 26526033
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid synthase (Fasn) inhibits the expression levels of immune response genes via alteration of alternative splicing in islet cells.
Wang K; Li L; Jin J; An Y; Wang Z; Zhou S; Zhang J; Abuduaini B; Cheng C; Li N
J Diabetes Complications; 2022 Jun; 36(6):108159. PubMed ID: 35210136
[TBL] [Abstract][Full Text] [Related]
11. A novel correlation between ATP5A1 gene expression and progression of human clear cell renal cell carcinoma identified by co‑expression analysis.
Yuan L; Chen L; Qian K; Wang G; Lu M; Qian G; Cao X; Jiang W; Xiao Y; Wang X
Oncol Rep; 2018 Feb; 39(2):525-536. PubMed ID: 29207195
[TBL] [Abstract][Full Text] [Related]
12. Transformer 2β regulates the alternative splicing of cell cycle regulatory genes to promote the malignant phenotype of ovarian cancer.
Zhou T; Fu P; Chen D; Liu R
Oncol Res; 2023; 31(5):769-785. PubMed ID: 37547760
[TBL] [Abstract][Full Text] [Related]
13. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
14. Loss of ATP5A1 enhances proliferation and predicts poor prognosis of colon adenocarcinoma.
Zhang G; Zhong J; Lin L; Liu Z
Pathol Res Pract; 2022 Feb; 230():153679. PubMed ID: 35007851
[TBL] [Abstract][Full Text] [Related]
15. The putative tumour modifier gene ATP5A1 is not mutated in human colorectal cancer cell lines but expression levels correlate with TP53 mutations and chromosomal instability.
Seth R; Keeley J; Abu-Ali G; Crook S; Jackson D; Ilyas M
J Clin Pathol; 2009 Jul; 62(7):598-603. PubMed ID: 19261598
[TBL] [Abstract][Full Text] [Related]
16. SRSF6 regulates alternative splicing of genes involved in DNA damage response and DNA repair in HeLa cells.
Yang X; Zhan P; Feng S; Ji H; Tian W; Wang M; Cheng C; Song B
Oncol Rep; 2020 Nov; 44(5):1851-1862. PubMed ID: 32901876
[TBL] [Abstract][Full Text] [Related]
17. RALY regulate the proliferation and expression of immune/inflammatory response genes via alternative splicing of FOS.
Liang Z; Rehati A; Husaiyin E; Chen D; Jiyuan Z; Abuduaini B
Genes Immun; 2022 Dec; 23(8):246-254. PubMed ID: 35941292
[TBL] [Abstract][Full Text] [Related]
18. Ribosomal protein L8 regulates the expression and splicing pattern of genes associated with cancer-related pathways.
Xu L; Yang G; Song B; Chen D; Yunus A; Chen J; Yang X; Tian Z
Turk J Biol; 2023; 47(5):313-324. PubMed ID: 38155938
[TBL] [Abstract][Full Text] [Related]
19. Tristetraprolin specifically regulates the expression and alternative splicing of immune response genes in HeLa cells.
Tu Y; Wu X; Yu F; Dang J; Wang J; Wei Y; Cai Z; Zhou Z; Liao W; Li L; Zhang Y
BMC Immunol; 2019 May; 20(1):13. PubMed ID: 31046669
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha regulates alternative splicing of genes participating in pathways of crucial metabolic syndromes; a transcriptome wide study.
Louis JM; Vaz C; Balaji A; Tanavde V; Talukdar I
Cytokine; 2020 Jan; 125():154815. PubMed ID: 31476685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
